Viewing StudyNCT01991938



Ignite Creation Date: 2024-05-06 @ 2:13 AM
Last Modification Date: 2024-10-26 @ 11:15 AM
Study NCT ID: NCT01991938
Status: TERMINATED
Last Update Posted: 2017-01-27
First Post: 2013-11-18

Brief Title: Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Sponsor: Verastem Inc
Organization: Verastem Inc

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Non Hematologic Cancers
Metastatic Cancer
Keywords:
Name View
Cancer Stem Cells View
PI3K Inhibitor View
mTOR Inhibitor View
Dual PI3KmTOR Inhibitor View
CSC View